Literature DB >> 15955578

Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin.

Andrew B Singleton1.   

Abstract

The past decade has been a fruitful one for geneticists involved in Parkinson's disease (PD) research. The initial hurdle of identifying the first gene underlying parkinsonism was cleared with apparent ease in 1997 and four additional genes have since been found to contain mutations causing this disorder. Driving this research is the belief that these data will highlight disease mechanisms and directly implicate a pathway amenable to therapeutic intervention. This article will focus on recent genetic advances in the field, focusing on data that suggest alpha-synuclein expression is key in the etiology of PD. In addition, it will discuss the recent identification of LRRK2 mutation as a cause of PD and the potential of this finding to provide further insight into disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955578     DOI: 10.1016/j.tins.2005.05.009

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  16 in total

1.  The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.

Authors:  A M Schlitter; D Woitalla; T Mueller; J T Epplen; G Dekomien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07       Impact factor: 10.154

2.  Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.

Authors:  Jeanne C Latourelle; Audrey E Hendricks; Nathan Pankratz; Jemma B Wilk; Cheryl Halter; William C Nichols; James F Gusella; Anita L Destefano; Richard H Myers; Tatiana Foroud
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 3.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

4.  Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.

Authors:  Yuyu Niu; Xiangyu Guo; Yongchang Chen; Chuan-En Wang; Jinquan Gao; Weili Yang; Yu Kang; Wei Si; Hong Wang; Shang-Hsun Yang; Shihua Li; Weizhi Ji; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

5.  Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.

Authors:  Mali Jiang; Yair Porat-Shliom; Zhong Pei; Yong Cheng; Lan Xiang; Katherine Sommers; Qing Li; Frank Gillardon; Bastian Hengerer; Cynthia Berlinicke; Wanli W Smith; Donald J Zack; Michelle A Poirier; Christopher A Ross; Wenzhen Duan
Journal:  J Neurochem       Date:  2010-04-19       Impact factor: 5.372

6.  Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome.

Authors:  Arthur P Chou; Nigel Maidment; Rebecka Klintenberg; John E Casida; Sharon Li; Arthur G Fitzmaurice; Pierre-Olivier Fernagut; Farzad Mortazavi; Marie-Francoise Chesselet; Jeff M Bronstein
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

7.  Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Li Rebekah Feng; Kathleen Maguire-Zeiss; Gw Rebeck; Hilal A Lashuel; Charbel Eh Moussa
Journal:  Mol Neurodegener       Date:  2010-11-04       Impact factor: 14.195

8.  Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry.

Authors:  Inês Sousa; Taane G Clark; Richard Holt; Alistair T Pagnamenta; Erik J Mulder; Ruud B Minderaa; Anthony J Bailey; Agatino Battaglia; Sabine M Klauck; Fritz Poustka; Anthony P Monaco
Journal:  Mol Autism       Date:  2010-03-25       Impact factor: 7.509

9.  Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.

Authors:  Baek-Soo Han; Lorraine Iacovitti; Taku Katano; Nobutaka Hattori; Wongi Seol; Kwang-Soo Kim
Journal:  Neurosci Lett       Date:  2008-07-10       Impact factor: 3.046

10.  Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy.

Authors:  Margot Fournier; Jérémie Vitte; Jérôme Garrigue; Dominique Langui; Jean-Philippe Dullin; Françoise Saurini; Naïma Hanoun; Fernando Perez-Diaz; Fabien Cornilleau; Chantal Joubert; Héctor Ardila-Osorio; Sabine Traver; René Duchateau; Cécile Goujet-Zalc; Katerina Paleologou; Hilal A Lashuel; Christian Haass; Charles Duyckaerts; Charles Cohen-Salmon; Philipp J Kahle; Michel Hamon; Alexis Brice; Olga Corti
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.